Incidence of serum antibodies to xenoantigens on triple-knockout pig cells in different human groups
- PMID: 37529830
- DOI: 10.1111/xen.12818
Incidence of serum antibodies to xenoantigens on triple-knockout pig cells in different human groups
Abstract
Background: Xenoantigens other than Gal, Neu5Gc, and Sda may be playing a role in pig graft rejection. We investigated the incidence of antibodies to unknown pig xenoantigen in different human groups.
Methods: We collected blood from TKO/hCD55 pigs (n = 3), and isolated PBMCs and RBCs. Serum samples were collected from (i) healthy human volunteers (n = 43), (ii) patients with end-stage renal disease (ESRD) (n = 87), (iii) the same patients after kidney allotransplantation (n = 50), and (iv) renal allotransplant recipients experiencing T cell-mediated rejection (allo-TCMR, n = 10). The sera were initially incubated with TKO/hCD55 pRBCs (1 × 108 cells) for 1 h to absorb anti-pig antibodies (except against SLA and possibly other antigens not expressed on pRBCs) and then the serum (absorbed or unabsorbed) was tested for antibody binding and complement-dependent cytotoxicity (CDC) to TKO/hCD55 pig PBMCs.
Results: A significant reduction in IgM/IgG binding and CDC was observed in the absorbed sera. Serum obtained before and after renal allotransplantation showed no significant difference in IgM or IgG binding to, or in CDC of, TKO/hCD55 pig cells. IgM antibodies (but rarely IgG) against unknown xenoantigens expressed on TKO/hCD55 PBMCs, possibly against swine leukocyte antigens, were documented in healthy humans, patients with ESRD, and those with renal allografts undergoing acute T cell rejection. IgM (but not CDC) was higher in patients experiencing allo-TCMR.
Conclusion: Human sera contain IgM antibodies against unknown pig xenoantigens expressed on TKO/hCD55 pPBMCs. Although not confirmed in the present study, the targets for these antibodies may include swine leukocyte antigens.
Keywords: antibodies; gene editing; pig; xenoantigens.
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Huang J. Report on Organ Transplantation Development in China (2020) [M]. China Science and Technology Press; 2022. (In Chinese).
-
- Adams AB, Lovasik BP, Faber DA, et al. Anti‐C5 antibody tesidolumab reduces early antibody‐mediated rejection and prolongs survival in renal xenotransplantation. Ann Surg 2021;274(3):473.
-
- Mohiuddin MM, Singh AK, Corcoran PC, et al. Chimeric 2C10R4 anti‐CD40 antibody therapy is critical for long‐term survival of GTKO.hCD46. hTBM pig‐to‐primate cardiac xenograft. Nat Commun 2016;7:11138.
-
- Firl DJ, Markmann JF. Measuring success in pig to non‐human‐primate renal xenotransplantation: systematic review and comparative outcomes analysis of 1051 life‐sustaining NHP renal allo‐ and xeno‐transplants. Am J Transplant 2022;22(6):1527.
-
- Hara H, Yamamoto T, Wei HJ, Cooper DKC. What have we learned from In vitro studies about pig‐to‐primate organ transplantation? Transplantation 2023;107(6):1265‐1277.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical